Company intelligence / Profile preview
Zhejiang Institute of Traditional Chinese Medicine
- Ownership
- Private
- Development stage
- Other
Overview
The company has developed at least one approved herbal medicine, Kunxinning Granules, for menopausal syndrome. There are two clinical trials associated with the company, but detailed results are not publicly available. The organization focuses on traditional Chinese medicine research and development.[4]
- Therapeutic areas
- Women's Health
- Modalities
- Herbal medicine
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Zhejiang Institute of Traditional Chinese Medicine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Institute of Traditional Chinese Medicine.